TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Jucker Pharma AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 1,042 | 977 | 2,107 |
Financial expenses | 461 | 136 | 211 |
Earnings before taxes | -591 | 35 | 592 |
EBITDA | -235 | 103 | 750 |
Total assets | 4,309 | 2,990 | 3,482 |
Current assets | 4,281 | 2,962 | 3,451 |
Current liabilities | 3,435 | 1,532 | 1,925 |
Equity capital | 875 | 1,458 | 1,556 |
- share capital | 67 | 67 | 73 |
Employees (average) | 2 | 3 | 4 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 20.3% | 48.8% | 44.7% |
Turnover per employee | 521 | 326 | 527 |
Profit as a percentage of turnover | -56.7% | 3.6% | 28.1% |
Return on assets (ROA) | -3.0% | 5.7% | 23.1% |
Current ratio | 124.6% | 193.3% | 179.3% |
Return on equity (ROE) | -67.5% | 2.4% | 38.0% |
Change turnover | 60 | -960 | -126 |
Change turnover % | 6% | -50% | -6% |
Chg. No. of employees | -1 | -1 | 0 |
Chg. No. of employees % | -33% | -25% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.